Evidence map›Paper›PMID 37201525›Full record

ArticleMolecular therapy : the journal of the American Society of Gene Therapy2023

Always a bridesmaid, never a bride: Committing to flu neuraminidase as a vaccine target.

Cosette Schneider, Lynda Coughlan

Open access · bronzeAbstract readComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular therapy : the journal of the American Society of Gene Therapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Cosette SchneiderDepartment of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201, USA; Graduate Program in Life Sciences (GPILS), Molecular Microbiology and Immunology Program, University of Maryland School of Medicine Baltimore, Baltimore, MD 21201, USA.
Lynda CoughlanDepartment of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201, USA; Center for Vaccine Development and Global Health (CVD), University of Maryland School of Medicine, Baltimore, MD 21201, USA. Electronic address: lcoughlan@som.umaryland.edu.
University of Maryland, Baltimore · US

Funding

COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS: CLINICAL CORE75N93019C00055 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI FRANKENFIELD, JILL · 2019 to 2025
$33.8M
Combining innovative molecular adjuvanting approaches with novel adenoviral vector delivery to generate a universal influenza vaccineR01AI148369 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI COUGHLAN, LYNDA · 2022 to 2025
$2.0M
Exosome-display as a strategy to enhance the immunogenicity of SARS-CoV-2 vaccines based on adenoviral vectorsR21AI157606 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI COUGHLAN, LYNDA · 2020 to 2020
$425k
NIAID NIH HHS 75N93019C00055NIAID NIH HHS R01 AI148369NIAID NIH HHS R21 AI157606
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Influenza, HumanInfluenza VaccinesVaccinesHumansNeuraminidaseInfluenza VaccinesNeuraminidaseVaccines

Identifiers

PMID37201525
PMCPMC10362412
OpenAlexW4376868592

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.